section name header

Pronunciation

FELL-ba-mate

Classifications

Therapeutic Classification: anticonvulsants

Indications

REMS

Action

Therapeutic Effects:

Pharmacokinetics

Absorption: Well absorbed following oral administration.

Distribution: 0.7 L/kg.

Metabolism/Excretion: 40–50% excreted unchanged in urine; 40% metabolized by the liver.

Half-life: 20–23 hr.

Time/Action Profile

(blood levels)

ROUTEONSETPEAKDURATION
POunknown1–6 hrunknown

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Derm: acne, rash.

EENT: diplopia, pharyngitis, rhinitis, sinusitis.

GI: anorexia, constipation, dyspepsia, nausea, vomiting, ACUTE LIVER FAILURE, altered taste, diarrhea, hiccups.

Hemat: APLASTIC ANEMIA.

MS: myalgia.

Neuro: dizziness, drowsiness, fatigue, headache, insomnia, psychological disturbances, anxiety, ataxia , SUICIDAL THOUGHTS.
Misc: flu-like syndrome, weight loss.

Interactions

Drug-Drug:

Drug-Natural Products:

Route/Dosage

see Calculator

Availability

(Generic available)

Assessment

Lab Test Considerations: Toxicity and Overdose:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Felbatol